AI in medicine, in plain English
How far away is that breakthrough, really?
Every week there's a headline about AI curing something. We check the evidence, rate how close it really is, show where it's approved around the world, and tell you what it means for you and what to ask your doctor. No hype, no medical advice, just honest answers.
Browse the tracker Get the weekly email
- Every claim linked to its source
- Ratings never higher than the evidence
- Independently reviewed pages
Front page ·
Top stories
More stories
- Drug discovery
AlphaFold 3: predicting how the molecules of life fit together
AlphaFold 3, published in Nature in May 2024 by Google DeepMind and Isomorphic Labs, predicts how proteins interact with DNA, RNA and drug-like molecules.
Updated
- Prediction and risk
Delphi-2M: AI that forecasts risk of 1,000+ diseases
Delphi-2M, a GPT-style model published in Nature in September 2025, learned from health records of about 400,000 UK Biobank participants to predict rates of more than 1,000 diseases.
Updated
- Diagnosis (general)
AMIE: Google's diagnostic chatbot research
Google's AMIE is a research AI that takes a medical history by text chat.
Updated
Cancer
More cancer stories →Heart and lungs
More heart and lungs stories →Drugs and discovery
More drugs and discovery stories →Diagnosis and imaging
More diagnosis and imaging stories →AI doctors and chatbots
More ai doctors and chatbots stories →How our ratings work
Cleared, authorised or approved by a regulator (we say where). We say separately when we've confirmed it's used with patients.
Being tested in people in a registered trial. Not approved for routine use.
Lab, computer or past-records studies. Not yet tested on patients going forward.
A company or press claim without published data we could find.
A rating can never be higher than the evidence behind it. Read our editorial standards.
The How Far weekly
One short email every week: what's new, what's hype, and what's changed on the tracker. Free. Unsubscribe any time.
Who's behind How Far?
How Far is an independent publication run by the How Far team, curious non-doctors who got tired of headlines that promise miracles. We check pages against primary studies and regulator records where we can find them, and say when we couldn't. Each page says whether it has had an independent review. More about us.